Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Survival outcomes of patients with concomitant acute variceal bleeding and acute coronary syndrome, and the role of antiplatelet agents: an institutional experience from a lower middle-income Country

Fig. 1

Incidence of Acute variceal bleeding (AVB) and Acute coronary events on follow up. One patient in the group without antiplatelet use developed recurrent AVB on day 10. Two patients with antiplatelet use developed acute coronary event; one at day 20, and other at day 150, on mean follow up of 180 days

Back to article page